MedTrace Logo

Varicella Vaccination With Pulmicort

NCT00641446 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2009-03-25

No results posted yet for this study

Summary

A study to determine whether treatment with Pulmicort in children has any effect on the varicella vaccine

Conditions

Interventions

DRUG

budesonide

DRUG

varicella zoster virus

Sponsors & Collaborators

Principal Investigators

  • Bertill Andersson · AstraZeneca employee

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Months
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2003-10-31
Completion
2003-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641446 on ClinicalTrials.gov